City
Epaper

'Vax drive for teens strengthened India's fight against Covid'

By IANS | Updated: January 13, 2022 21:05 IST

New Delhi, Jan 13 The ongoing vaccination drive for teenagers in the 15-18 age bracket has further strengthened ...

Open in App

New Delhi, Jan 13 The ongoing vaccination drive for teenagers in the 15-18 age bracket has further strengthened India's fight against the Covid-19 pandemic, N.K. Arora, Chairman of the Covid-19 Working Group of National Technical Advisory Group on Immunisation (NTAGI), told on Thursday.

"Vaccinating teenagers will give parents the confidence to send them to school and help them resume normal activities while maintaining Covid appropriate behaviour," Arora said.

Since the beginning of the vaccination drive for the 15 to 18 age group on January 3, over three crore teens have been vaccinated with the first dose so far. As per an estimation, there are around 7.50 crore teens in this age bracket in India to whom vaccine shots will be administered.

Talking about Ahmedabad-based Zydus Cadilla's ZyCovD vaccine, the world's first plasmid-DNA vaccine approved for those above 12 years, Arora said, "Since it is the first DNA vaccine, the government wants to be doubly sure of its safety before providing it to children. So, its first one crore doses will be given to adults."

"The vaccine was found to be absolutely safe and highly efficacious during the trials. We are sure that it will soon be available for children as well," he said.

"Data shows that children are as susceptible to catching the infection as adults are. The vaccine protects against severe disease. The older teenagers are quite socially active and so they are at a higher risk of catching the virus as compared to younger kids.

"

On vaccine's side-effects among teens, Manju Puri, consultant gynaecologist at Lady Hardinge Medical College, said that it is a time-tested technology which is both safe and efficacious.

No major side-effects have been reported yet, she said, adding that children, like adults, may experience mild side-effects such as pain at the vaccine site, fatigue, or mild fever for a few days.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: New DelhiindiaCovid-19 working group of national technical advisory group on immunisationNtagiManju puri
Open in App

Related Stories

OpinionsWhy is Trump So Upset with India?

MumbaiUniversity of Bristol Chooses Mumbai for Its First Overseas Campus, Set to Open in September 2026

NationalRaksha Bandhan 2025: Now You Can Send a Rakhi to Your Brother in India Post's Waterproof Envelope — Here's How to Track Your Parcel

NationalGold in Dubai Cheaper Than India: Pricing, Rules, and Import Limits Explained

NationalIndia Spends ₹1.38 Lakh Crore Annually on Edible Oil Imports

Health Realted Stories

HealthAyush Ministry, NMPB sign MoUs to boost conservation, awareness of medicinal plants

HealthStudy explores role of brain in treating type 1 diabetes

HealthHyderabad has become global GCC hub, says CM Revanth Reddy

HealthKnow 5 Nutrient-Rich Foods That Sharpen Your Mind and Strengthen Memory

Health'My thoughts are with Hemant ji': PM Modi pays tribute to Shibu Soren at Ganga Ram hospital, expresses condolences to family